ACAD Stock: ACADIA Pharmaceuticals Inc. Stock Price, Analysis & Insights
Get live ACAD stock price $21.49, comprehensive ACADIA Pharmaceuticals Inc. stock analysis, charts, news, and expert forecast. Real-time ACAD stock data and investment insights.
Loading chart data...
ACADIA Pharmaceuticals Inc. (ACAD) Overview
ACADIA Pharmaceuticals Inc. (ACAD) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, ACAD trades at $21.49 with a market capitalization of 3.68B . Over the past 52 weeks, ACAD has traded between $19.69 and $28.35 , with the current price positioned at approximately 21% of this range . The stock currently tr...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 3.68B
- Current price: $21.49
- 52-week range: $19.69 - $28.35
- P/E ratio: 9.73
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of...
Company Information
- CEO
- Catherine E. Owen Adams
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 653
Contact Information
- Website
- https://www.acadia-pharm.com
- Address
- 12830 El Camino Real
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 9.7)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for ACADIA Pharmaceuticals Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for ACADIA Pharmaceuticals Inc.
- ⚠Investors should consider how ACADIA Pharmaceuticals Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.68B
P/E Ratio (TTM)
9.73
Beta
0.83
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ACAD with peer companies:
- Price
- $8.58
- Market cap
- 1.99B
- Price
- $139.72
- Market cap
- 5.60B
- Price
- $35.15
- Market cap
- 3.71B
- Price
- $17.88
- Market cap
- 2.96B
- Price
- $31.49
- Market cap
- 6.47B
- Price
- $248.77
- Market cap
- 4.99B
- Price
- $95.30
- Market cap
- 4.78B
- Price
- $242.83
- Market cap
- 5.13B
- Price
- $53.01
- Market cap
- 2.76B
- Price
- $27.97
- Market cap
- 3.25B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.